News

The tie up allows the scientists of the two institutions to work together and take forward these discoveries to the next stage of research by identifying compounds that

The inspection was done by the representatives of the FDA, EMA from the Medicines and Healthcare products Regulatory Agency (MHRA) and Medical Products Agency of Sweden (MPA). As

Under an agreement signed between both the companies, Skinvisible has given Canadian marketing rights of DermSafe to Alto. Alto expects to market the product under the name DermSafePC. DermSafe

Ridaforolimus is an experimental oral mTOR inhibitor developed as a treatment for patients with metastatic soft-tissue or bone sarcomas  who had a favorable response to chemotherapy. Earlier, ARIAD and

Extedo claims, the version 2.0 SP1 features new Graphical User Interface (GUI), faster automatic validation set detection, new ways to add new sequences, parallel mass validation support, improved

The prenatal test is developed utilizing the company’s bioinformatics technology – Parental Support which unites single-nucleotide polymorphism (SNP) technology with bioinformatics algorithms to produce genetic information from small

Folotyn is approved in the US as a treatment for the patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). The study aims to determine the efficacy and

Sugardown is intended to help in the reduction of post-meal elevation of blood glucose. In the trial, Sugardown was evaluated in overweight healthy adults with a mean body

Scancell is developing SCIB1 for the treatment of cancer and infectious diseases based on its ImmunoBody technology platform. The trial, which was started in June 2010, is intended